Related Experiment Videos
Anesthetic potency of nalbuphine and interaction with morphine in rats
Abstract:
The contribution to anesthesia by nalbuphine was determined in rats by measurement of the reduction in the anesthetic requirement for cyclopropane produced by increasing doses of nalbuphine while maintaining a constant level of anesthesia (MAC). The respiratory effect of nalbuphine was evaluated by measurement of arterial PCO2 at this constant MAG level. The response produced by the addition of morphine to a constant dose of nalbuphine in further reducing the cyclopropane anesthetic requirement was also evaluated, as was the effect on arterial PCO2. The anesthetic contribution of nalbuphine was dose dependent until a plateau contribution of 0.22 MAC was achieved. Arterial PCO2 increased to a plateau level of 48 torr with nalbuphine administration from a PCO2 of 41 torr with cyclopropane alone. Further increase in PCO2 did not occur until exceedingly high nalbuphine doses were used. Morphine did not supplement the anesthetic contribution of nalbuphine, and there was no increase in PCO2 when morphine was added in nalbuphine during cyclopropane anesthesia. These results suggest that nalbuphine produces analgesia by acting at kappa opioid receptors and that nalbuphine binds but produces minimal effects on mu opioid receptors within the central nervous system.
Insights
Nalbuphine reduces anesthetic needs in rats, acting on kappa opioid receptors. It increases carbon dioxide levels but does not enhance anesthesia when combined with morphine.
Area of Science:
- Anesthesiology
- Pharmacology
- Neuroscience
Background:
- The anesthetic properties of nalbuphine, an opioid agonist-antagonist, are not fully understood.
- Investigating nalbuphine's contribution to anesthesia and its respiratory effects is crucial for clinical application.
Purpose of the Study:
- To quantify the anesthetic contribution of nalbuphine in rats.
- To evaluate the respiratory effects of nalbuphine during anesthesia.
- To determine if morphine can potentiate nalbuphine's anesthetic effects.
Main Methods:
- Rats were administered increasing doses of nalbuphine to determine the reduction in cyclopropane anesthetic requirement (MAC).
- Arterial PCO2 was measured to assess respiratory effects at constant MAC.
- Morphine was added to nalbuphine to evaluate combined anesthetic and respiratory effects.
Main Results:
- Nalbuphine's anesthetic contribution was dose-dependent, plateauing at 0.22 MAC.
- Arterial PCO2 increased from 41 to 48 torr with nalbuphine, reaching a plateau.
- Morphine did not enhance nalbuphine's anesthetic effect or further increase PCO2.
Conclusions:
- Nalbuphine likely produces analgesia via kappa opioid receptors.
- Nalbuphine has minimal interaction with mu opioid receptors in the central nervous system.
- Nalbuphine provides a dose-dependent anesthetic contribution with a notable effect on respiratory drive.